|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/24 | (2006.01) |
| A61K 31/4418 | (2006.01) | ||
| A61K 31/5377 | (2006.01) | ||
| A61P 31/12 | (2006.01) | ||
| A61P 31/18 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 3421033 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18179796.0 |
| Date of filing the European patent application | 2014-10-06 | |
| (97) | Date of publication of the European application | 2019-01-02 |
| (45) | Date of publication and mention of the grant of the patent | 2022-07-27 |
| (46) | Date of publication of the claims translation | 2022-11-10 |
| (30) | Number | Date | Country code |
| 201361887574 P | 2013-10-07 | US |
| (72) |
KOO, Otilia May Yue , US
NIKFAR, Faranak , US
TAO, Jing , US
KOTTALA, Niranjan Kumar , IN
VARIA, Sailesh A. , US
|
| (73) |
Bristol-Myers Squibb Holdings Ireland
Unlimited Company ,
Hinterbergstrasse 16, 6312 Steinhausen,
CH
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Atazanaviro ir kobicistato kompozicija, skirta ŽIV gydymui |
| HIV TREATMENT FORMULATION OF ATAZANAVIR AND COBICISTAT |
| Payment date | Validity (years) | Amount | |
| 2025-09-02 | 12 | 289.00 EUR |
| 2026-10-06 |